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Abstract We investigated which molecules are selected from a 
model library by the selectively infective phage (SIP) methodol-
ogy. As a model system, we used the fluorescein binding single-
chain Fv fragment FITC-E2, and from a 3D-model, we identified 
11 residues potentially involved in hapten binding and mutated 
them individually to alanines. The binding constant of each 
mutant was determined by fluorescence titration, and each 
mutant was tested individually as well as in competitive SIP 
experiments for infectivity. After three rounds of SIP, only 
molecules with KD values within a factor of 2 of the tightest 
binder remain, and among those, a mutant no longer carrying an 
unnecessary exposed tryptophan residue is preferentially se-
lected. SIP is shown to select for the best overall properties of the 
displayed molecules, including folding behavior, stability and 
affinity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The selectively infective phage technology [1-11] selects for 
binding events by directly coupling infection of E. coli by 
filamentous phages to the association of two interacting mol-
ecules. This method thus completely avoids solid phase bind-
ing of phages and their elution. Selective infection is achieved 
by breaking up the gene-3-protein (g3p), which is needed for 
the infection process, into two fragments. The C-terminal do-
main, part of the phage coat, is fused to one of the interacting 
molecules, in our case a single-chain Fv fragment (scFv) of an 
antibody. The resulting phage is completely non-infectious 
[12-15]. This is in contrast to phage display [16], where in-
fective phages are used. 
For infection, the phage is missing both the N-terminal 
domains Nl (involved in penetration of the bacterial mem-
brane) [15,17] and N2 (involved in docking to the F-pilus) 
[15,18] of g3p. These are supplied together in the form of a 
separate soluble adapter protein, fused to the other interacting 
molecule. In our case, the antigen fluorescein was chemically 
coupled to an engineered cysteine at the C-terminus of N2 
(Fig. 1). 
Previous experiments [7] with an anti-fluorescein scFv have 
shown that the infection event is strictly dependent on the 
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coupling of fluorescein to the adapter protein. No infection 
is observed if the adapter does not carry antigen, demonstrat-
ing that the N-terminal domains need to be physically coupled 
to the phage (via the antibody-antigen interaction) and do not 
simply permeabilize the bacterial membrane. The dependence 
of infection on N1-N2 adapter concentration shows a concen-
tration optimum. Presumably, at high concentrations, adapter 
binds to both pilus and phage and thereby blocks the infec-
tion process. 
In this study, we have investigated the dependence of the 
infection efficiency on the dissociation constant of an anti-
body-antigen pair. As a model system, we have used the 
anti-fluorescein antibody FITC-E2 [19], which binds fluores-
cein with a dissociation constant Ko of about 7.5-10-10 M. To 
create a panel of closely related antibodies with different bind-
ing constants, we built a model of the scFv fragment and 
identified potential antigen binding residues as those amino 
acids whose side chains are close to the two-fold molecular 
axis, relating VH and VL. Residues with side chains pointing 
into the binding pocket were individually mutated to alanines, 
and the binding constants determined by fluorescence spec-
troscopy. The infectivity of the resulting phages was then 
determined in individual SIP experiments, and they were 
tested in competitive experiments over one and three rounds. 
2. Materials and methods 
2.1. Molecular modeling 
A molecular model for the lambda VL domain of the antibody 
FITC-E2 was built on the basis of the structure of the Fab fragment 
KOL (75% sequence identity at the amino acido level, 81% similarity, 
PDB file 2fb4, 1.9 Á resolution) and 2ig2 (3.0 Á res.). The structures 
of the Bence-Jones protein LOC (71% identity, 80% similarity, file 
lbjm, 2.4 Á res.) and the light chain dimer MCG (73% identity, 
79% similarity, file lmcb, 2.7 A res.) were used for comparison. The 
VH domain was modeled according to the structures of the Fab frag-
ment of antibody structures 2fbj (64% identity, 73% similarity, 1.95 Â 
res.), while structures ligc (73% identity, 77% similarity, 2.6 A res.) 
and 2gfb (72% identity, 75% similarity, 3.0 A res.) were used for 
comparison. 
With a length of 18 amino acids, the CDR3 loop of FITC-E2 VH 
was longer than any found in the PDB database (likf, ldfb, 2fb4 are 
17 aa, lopg is 16 aa, lfai is 15 aa). The structure of a loop of this 
length cannot be predicted reliably and is presumably flexible. How-
ever, the overall direction of these long loops is determined by the 
presence or absence of the Arg-H94/Asp-H101 salt bridge, which is 
present in FITC-E2. Therefore, the conformation of the first and last 
six amino acids of the loop were taken from the structure ldfb, the 
6 amino acids at the tip filled in by a conformational search, and the 
entire loop was allowed to relax by a molecular dynamics annealing. 
All modeling was performed using the Insightll 95/Discover 95 soft-
ware packages (Biosym/MSI, San Diego). 
2.2. Molecular biology 
Site directed mutagenesis was carried out with the SIP fCKC-E2, 
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encoding the w.t. scFv FITC-E2 [7], by the method of Kunkel [20], 
and confirmed by sequencing. The mutated scFv gene was recloned as 
a Sfil-SfiT cassette into the expression vector pAK400 [21], and re-
cloned into the SIP vector. 
2.3. Expression and purification of scFv fragments 
The soluble scFv fragments were purified from E. coli SB536 [22], 
harboring the pAK400-based secretion vectors. The cells (2 1) were 
grown at 25°C, induced at an OD550 of 0.5, grown for a further 3.5 h, 
centrifuged and resuspended in 15-20 ml IMAC buffer (20 mM 
HEPES, 150 mM NaCl, pH 7.0) on ice, and passed three times 
through a French Press. The suspension was centrifuged (48000Xg, 
4°C) and the supernatant was passed through a 0.22 um sterile filter. 
The protein was purified on a Ni2+-NTA column (Qiagen) with a step 
gradient and eluted at 100 mM imidazole. It was then concentrated, 
with a buffer change to 20 mM MES, pH 6.0, 50 mM NaCl. The 
remaining impurities were removed on a Sepharose-SP column (Phar-
macia) in the same buffer, using a NaCl step gradient, where the scFv 
samples eluted at 130-175 mM NaCl. The final protein concentration 
was determined from the OD280 according to Gill and von Hippel 
[23]. 
2.4. Fluorescence titration 
The dissociation constant of fluorescein was determined by measur-
ing the fluorescence spectra from 495 to 530 nm (excitation at 485 
nm), using a constant amount of fluorescein (usually 3.4 nM) and 
variable scFv concentrations, in a 2 ml cuvette at 18°C. The dissoci-
ation constant was determined by the following formula: 
Fcorr = FQ + (F„—FO) • 
[Flua 
I [scFv,0,]-fA + [Flu 
2 
\+KD 
variable, [scFvtot], and two adjustable parameters, the dissociation 
constant KD and the fraction of active protein f¿. When/4 was in-
dependently determined prior to the fluorescence titration, and 
[scFvu,t] therefore precisely corresponded to the active concentration, 
a value of 1.0 for / ¿ was obtained from the fit, demonstrating the 
robustness of the method. 
2.5. SIP experiments 
The preparation of adapter protein and coupling with fluorescein to 
give Nl-N2-Flu has been described previously [7]. Phages were pre-
pared from E. coli XL 1-Blue by PEG precipitation. The phage con-
centration was determined by ELISA, after directly coating the 
phages [7]. Functional (antigen binding) phage ELISAs were carried 
out by coating with fluorescein isothiocyanate coupled to bovine se-
rum albumin (BSA-FITC), and detecting bound phages with anti-
Mi 3 serum, as described previously [7]. 
Individual SIP experiments were carried out by incubating 10 ul of 
a 0.34 uM solution of Nl-N2-Flu in TBS buffer with 1 |xl phage 
suspension (between 1011 and 1014 phages, obtained from PEG-pre-
cipitated overnight culture) overnight at 4°C. To this mixture, 100 u.1 
of exponentially growing E. coli XLl-Blue (OD550 = 0.8 to 0.95) were 
added and incubated 1 h a t 37°C and plated on 2YT plates with cam 
(25 mg/1) and tet (15 mg/1). 
For competitive SIP experiments, approximately equal amounts of 
phages were mixed, and 1.5 ml E. coli were used. For one-round 
experiments, 31 clones were sequenced to identify the selected mu-
tants. For three-round experiments, after adding bacteria to phages 
and incubation for 1 h, two aliquots of 600 and 700 u.1 were diluted 
into 50 ml of 2YT, 1% glucose, 2% glycerin, 50 mM MgCl2, 25 mg/1 
cam, while 50 and 100 (xl were plated to determine the number of 
infection events. The hquid culture was grown overnight, phages were 
obtained from the supernatant and PEG-precipitated twice. These 
phages were then incubated with adapter for the next round. After 
the third round, cells were plated, and 44 clones were sequenced. 
f[scFv,„,]-fA + [Flu 
\ 2 
\+KD -[scFvl0,]-fA-[Flu c< 
Here, [Flucorr] is the total fluorescein concentration, which becomes 
automatically corrected for dilution [24]. This is achieved by directly 
substituting [Flucorr] = [Fluini]-([scFvatock\-[scFvm\)l[scFvsU>ck], which 
adjusts it for the added volume from the titration with scFv, starting 
from the initial value [Flumi\, where [scFvst0Ck] is the concentration of 
the stock solution. Fcmr is the fluorescence at the intensity maximum 
(512 nm), corrected for dilution effects, F0 is the fluorescence in the 
absence of scFv, and Fx is the final value at high [scFv] which was 
found to be insignificantly different from zero and was thus set to 
zero. The term [scFvtot] is the total concentration of scFv in the cu-
vette at each experimental point, calculated from OD280 of the stock 
solution. The above formula thus fits the observed fluorescence inten-
sity, corrected for dilution, directly as a function of one independent 
3. Results and discussion 
A molecular model of the antibody FITC-E2 [19] was built 
on the basis of the P D B structures of the antibodies K O L and 
J539. Because of the long C D R - H 3 , an uncertainty in the 
C D R - H 3 structure results, but the residues pointing toward 
the two-fold molecular axis, and thus to the presumed antigen 
binding pocket, can clearly be identified (Fig. 2). In C D R - H 2 , 
we individually mutated Arg-H53, Leu-H56 and His-H58, in 
C D R - H 3 Arg-H95, Trp-H100C, His-H100E, Phe-H100F and 
Tyr-H100G, while in CDR-L1 Asn-L31 and in C D R - L 3 Trp-
L91 and Asp-L93 were mutated, always to alanine (see Table 
1 for nomenclature). 
The resulting proteins were produced by secretion to the 
Table 1 
Summary of Ko determination and SIP experiments of alanine scan mutants of the antibody FITC-E2 
Mutant" KD (nM) Activity
b Frequency after 1-round SIPC Frequency after 3-round SIP 
exp A exp B exp C E(A-C) 
w.t. FITC-E2 
Arg-H53-Ala 
Leu-H56-Ala 
His-H58-Ala 
Arg-H95-Ala 
Trp-H100C-Ala 
His-H100E-Ala 
Phe-H100F-Ala 
Tyr-H100G-Ala 
Asn-L31-Ala 
Trp-L91-Ala 
Asp-L93-Ala 
0.75 
0.63 
0.74 
8.9 
no bind, detec. 
0.71 
1.6 
2.9 
3.1 
0.74 
0.71 
0.93 
0.86 
0.83 
0.84 
0.29 
-
0.89 
0.91 
0.70 
0.67 
0.87 
0.07 
0.80 
4 
6 
1 
0 
0 
30 
3 
0 
0 
0 
0 
0 
BNumbering scheme according to Kabat, where CDR residues inserted after position 100 carry letters, such as in 100G. Thus, Tyr-H100G-Ala 
means that tyrosine, present at position 100G of the heavy chain (H), has been changed to alanine. 
bCoefficient f¿ determined from fluorescence titration. It relates active protein to total purified protein, determined from OD28o-
cThree independent experiments. 
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Fig. 1. Principle of SIP. The adapter protein was prepared by refolding N1-N2 from inclusion bodies and chemically coupling fluorescein to an 
engineered cystein at the C-terminus of the protein [7]. The non-infective phage becomes infective when mixed with adapter in vitro, provided 
the antigen is recognized by the antibody. After incubating adapter and phage, bacteria are added and plated on selective media to select for 
camR, carried by the phage. 
E. coli periplasm as soluble and functional scFv, containing a 
C-terminal his-tag, and purified by IMAC, followed by ion-
exchange chromatography. The dissociation constant of fluo-
rescein was determined by fluorescence titration, using a con-
stant amount of fluorescein to which scFv was added in small 
portions, while measuring the resulting fluorescence quench-
ing. Using a correction term for active protein, excellent 
agreements with the theoretical curve (correlation coefficients 
of 99.99%) were obtained for all mutants (Fig. 3), except Arg-
H95, for which no quenching at all was found. This mutant 
was also the only one which did not give a significant phage 
ELISA signal in antigen binding assays, while all others were 
similar within experimental error. 
The resulting Kß values are summarized in Table 1. It can 
be seen that a large number of mutations, which are all on the 
periphery of the molecule, have almost no influence on bind-
ing, suggesting that the binding site is deep in the pocket. The 
antibody is remarkably resistant against mutation, with 5 mu-
tations giving rise to the same sub-nanomolar affinity of the 
w.t. One mutation, Arg-H95-Ala completely eliminates bind-
ing beyond detection. His-H58-Ala leads both to a 10-fold 
reduction in binding constant and to a low amount of func-
tional protein (30%) in the preparation of homogeneous, solu-
ble scFv. This suggests the presence of two different molecular 
species in solution, one with reduced affinity, the other with 
no affinity at all. The mutation Trp-L91-Ala also leads to only 
a low amount of functional protein (7%) in the preparation of 
homogeneous, soluble scFv, but the protein which is function-
al has essentially an unaltered binding affinity from w.t. While 
the phages carrying this mutated scFv also give a normal 
antigen binding phage ELISA signal, they differ from the 
others in that they cannot be inhibited with free fluorescein 
(data not shown). 
Interestingly, all proteins were obtained in comparable 
amounts upon expression of native protein and purification 
from E. coli. This suggests that the mutations Arg-H95-Ala, 
His-H58-Ala, Trp-L91-Ala do not appear to make the protein 
particularly unstable, insoluble or aggregation prone. Simi-
larly, all phages are produced at comparable levels. 
The w.t. and the 11 alanine-scan mutants were then tested 
in individual SIP experiments. Individual SIPs were prepared, 
and the infection events were measured as a function of 
adapter concentration. In all cases, except for Arg-H95-Ala, 
His-H58-Ala, Trp-L91-Ala, an optimum curve similar to the 
w.t. [7] was observed (data not shown). The number of phages 
were adjusted prior to the infection experiment according to 
an ELISA in which phages were coated and detected with an 
anti-M13 antiserum. However, this method is not accurate 
enough to eliminate small errors in phage concentration, 
and therefore, it is impossible to interpret any small differ-
ences in absolute infection rates. 
The three mutants which gave low percentages of active 
protein upon testing purified, soluble scFv (His-H58-Ala, 
Arg-H95-Ala and Trp-L91-Ala) also gave very much lower 
infectivities, indicating that the scFv fragment on the phage 
is also folded only to a small percentage. However, His-H58-
Ala and Trp-L91-Ala did lead to infection, when about 100-
fold higher phage concentrations were used (data not shown). 
In contrast, for Arg-H95-Ala, infections never exceeded the 
level of the background. 
We then investigated all mutants in competitive experi-
ments. First, the w.t. and the 11 mutant phages were mixed 
at approximately equimolar concentrations, and DNA from 
single colonies was sequenced after one round of SIP, i.e. after 
adding adapter protein (28 nM final concentration) and bac-
teria to the mixture. This experiment was carried out three 
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times independently, and Table 1 gives the results how often 
each mutant was found. It can be seen that all mutants are 
found at comparable levels, but the three mutations with a 
large decrease in affinity and/or folding defects (His-H58-Ala, 
Arg-H95-Ala and Trp-L91-Ala) are immediately lost. On the 
other hand, this experiment also shows that the discrimination 
between closely similar binding constants is very subtle under 
these conditions, if all are very tight binders, and requires 
more than one round of SIP. 
Thus, we carried out an experiment over three competitive 
rounds. In order to avoid accidental loss of phages in the first 
round, high numbers of phage were used in the first round 
(5-1010 phages for each species). After three rounds, Trp-
H100C-Ala was enriched, with w.t. Arg-H53-Ala, Leu-H56-
Ala, and His-H100E-Ala still present. Thus, all selected scFvs 
are within a factor 2 of the best binding constant. Neverthe-
less, the binding constant cannot be the only criterion, since 
Asn-L31-Ala and Asp-L93-Ala were lost, even though both 
have sub-nanomolar dissociation constants. Because of the 
relatively low infectivities of the phages, underrepresented 
phages can be lost fast in a competitive experiment, and we 
cannot exclude that the original mixture was not equimolar. 
The competitive selection experiments over three rounds 
enormously amplify small differences in selective advantage. 
It is likely that a combination of molecular properties is se-
lected, including affinity, folding efficiency, stability or any 
difference in toxic effect on the producing host. Thus, it is 
unlikely that binding affinity is the sole criterion of selection. 
Nevertheless, the only molecules surviving three rounds of SIP 
were those with a KD of 1.6 nM or better with good folding 
properties. The molecule getting enriched appears to be Trp-
H100C-Ala. Modeling suggests that this tryptophan is ex-
posed and apparently does not contribute to binding since 
its mutation to alanine has no effect. It is possible that this 
exposed tryptophan very slightly disfavors expression on 
phage, even though this difference is not measurable by phage 
1 106-
8-105-
S 6-105-
4-10s-
2-105-
o-
, a TrpHIOOCAIa 
MO"8 1.5-10"8 
[scFv] (M) 
2-10"8 2.510s 
4-10"8 6-10"8 
[scFv] (M) 
MO"7 
Trp L91 Ala 
0 5-10"8 MO"7 1.5-10"7 2-10"7 2.5-10"7 
[scFv] (M) 
Fig. 3. Three selected fluorescence titration curves for KD determi-
nation. The fit shown is according to the formula in Section 2, and 
the extracted parameters are summarized in Table 1. 
Fig. 2. Model of the fluorescein binding antibody FITC-E2. Resi-
dues mutated in this study are shown with their side chains. Those 
residues are shown in white whose mutation into alanine does not 
change the binding constant within experimental error, those which 
have a two- to four-fold higher KD are shown in grey and those 
with a serious defect in black. The numbering shown is according 
to Kabat, with H for heavy and L for light chain. 
ELISA (data not shown), and it becomes apparent only after 
three rounds of SIP. 
Further molecular properties, which are currently in the 
process of being determined, such as the association and dis-
sociation rate, may also influence the selection process. How-
ever, it is clear that the overall molecular properties will de-
termine the winner in competitive SIP experiments. In 
previous experiments using several anti-HIV peptide Fab frag-
ments [6], the selection for affinity and kinetic properties have 
been investigated. Similar to the experiments described here, 
the selection of antibodies with a dissociation constant of 10- 9 
M over those with one of 10~8 M was apparent, but any 
potential differences in functional expression and the folding 
properties of the Fab fragments were not tested quantita-
tively. 
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In conclusion, SIP appears a very powerful technique for 
selecting against poor binders and poor folders in a single 
round. Since, in contrast to phage display, there is no solid 
phase binding involved at any step, no complications result 
from poor elution of the best binders and from different re-
coveries of tight binders. Thus, small differences can be more 
easily amplified over several rounds and the best 'overall ' 
molecule identified, such as Trp-100C-Ala here. SIP thus ap-
pears to be very promising for screening of libraries which 
contain tight binders, and to be especially suited for molecular 
optimization. 
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